Marc A. Gavin
11Patents
5h-index
17Co-inventors
59Inventor score
Filing activity: Nov 8, 2012 → Dec 20, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9732134B2 | Method of treating graft versus host disease using IL-2 muteins | Human Necessities | 34 | Active |
| US9580486B2 | Interleukin-2 muteins for the expansion of T-regulatory cells | Chemistry; Metallurgy | 31 | Active |
| US9932380B2 | Interleukin-2 muteins for the expansion of T-regulatory cells | Chemistry; Metallurgy | 20 | Active |
| US10851144B2 | Interleukin-2 muteins for the expansion of T-regulatory cells | Chemistry; Metallurgy | 13 | Active |
| US10829535B2 | Interleukin-2 muteins for the expansion of T-regulatory cells | Chemistry; Metallurgy | 5 | Active |
| US9309318B2 | Compositions relating to anti-IL-21 receptor antibodies | Chemistry; Metallurgy | 1 | Active |
| US12297248B2 | Methods of treating graft versus host disease using IL-2 muteins | Human Necessities | 0 | Active |
| US11976102B2 | Interleukin-2 muteins for the expansion of T-regulatory cells | Chemistry; Metallurgy | 0 | Active |
| US11560415B2 | Method of promoting regulatory T-cell proliferation | Human Necessities | 0 | Active |
| US10184002B2 | Methods and compositions relating to anti-IL-21 receptor antibodies | Chemistry; Metallurgy | 0 | Active |
| US11976103B2 | Interleukin-2 muteins for the expansion of T-regulatory cells | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.